Integrative oncology has made great strides over the past decade, but does it help to increase 5-year survival odds? In this interview, NMJ founder Karolyn A. Gazella talks with integrative oncology researcher, patient advocate, and breast cancer survivor Terri Crudup. Crudup was a part of the research team that recently published a study on the efficacy of integrative oncology for breast cancer patients in the Journal of Oncology.
About the Expert
Terri Crudup is an integrative oncology researcher who is passionate about increasing education, support, and funding for integrative therapies. As a two-time cancer survivor, Terri learned the power of complementary and lifestyle therapies, integrating them with traditional treatments to maximize her outcomes. Terri’s employer, IQVIA, sponsored her research study showing institutional involvement with integrative oncology increases the odds of five-year survival for breast cancer patients. Her work has been published through ASCO and in the Journal of Oncology. Terri has a Biology degree from SUNY Geneseo, an MBA from the University of Rochester Simon School, and 20 years’ experience as a researcher and consultant to pharmaceutical companies.